FIM
JNCE

Freedom Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Freedom Investment Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-49,959
Closed -$417K – 984
2021
Q4 		$417K Buy
49,959
+19,320
+63% +$161K 0.03% 583
2021
Q3 		$228K Buy
30,639
+1,420
+5% +$10.6K 0.02% 717
2021
Q2 		$199K Buy
29,219
+10,800
+59% +$73.6K 0.01% 828
2021
Q1 		$189K Buy
+18,419
New +$189K 0.01% 797